메뉴 건너뛰기




Volumn 2013, Issue , 2013, Pages

The effect of weight loss in obese patients with chronic stable plaque-type psoriasis

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

EID: 84885612353     PISSN: None     EISSN: 16876113     Source Type: Journal    
DOI: 10.1155/2013/795932     Document Type: Article
Times cited : (21)

References (19)
  • 1
  • 2
    • 34548588714 scopus 로고    scopus 로고
    • Obesity in psoriasis: The metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review
    • DOI 10.1111/j.1365-2133.2007.08068.x
    • Sterry W., Strober B. E., Menter A., Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. The British Journal of Dermatology 2007 157 4 649 655 2-s2.0-34548588714 10.1111/j.1365-2133.2007.08068.x (Pubitemid 47389868)
    • (2007) British Journal of Dermatology , vol.157 , Issue.4 , pp. 649-655
    • Sterry, W.1    Strober, B.E.2    Menter, A.3
  • 4
    • 33846422032 scopus 로고    scopus 로고
    • Obesity and diabetes in the developing world - A growing challenge
    • DOI 10.1056/NEJMp068177
    • Hossain P., Kawar B., El Nahas M., Obesity and diabetes in the developing world-a growing challenge. The New England Journal of Medicine 2007 356 3 213 215 2-s2.0-33846422032 10.1056/NEJMp068177 (Pubitemid 46143224)
    • (2007) New England Journal of Medicine , vol.356 , Issue.3 , pp. 213-215
    • Hossain, P.1    Kawar, B.2    El Nahas, M.3
  • 5
    • 0344442356 scopus 로고    scopus 로고
    • The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. Study
    • Balkau B., Vernay M., Mhamdi L., Novak M., Arondel D., Vol S., Tichet J., Eschwège E., The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. Diabetes and Metabolism 2003 29 5 526 532 2-s2.0-0344442356 (Pubitemid 37474265)
    • (2003) Diabetes and Metabolism , vol.29 , Issue.5 , pp. 526-532
    • Balkau, B.1    Vernay, M.2    Mhamdi, L.3    Novak, M.4    Arondel, D.5    Vol, S.6    Tichet, J.7    Eschwege, E.8
  • 6
    • 33845866857 scopus 로고    scopus 로고
    • Inflammation and metabolic disorders
    • DOI 10.1038/nature05485, PII NATURE05485
    • Hotamisligil G. S., Inflammation and metabolic disorders. Nature 2006 444 7121 860 867 2-s2.0-33845866857 10.1038/nature05485 (Pubitemid 46024993)
    • (2006) Nature , vol.444 , Issue.7121 , pp. 860-867
    • Hotamisligil, G.S.1
  • 7
    • 34250674798 scopus 로고    scopus 로고
    • Prevalence of metabolic syndrome in patients with psoriasis: A hospital-based case-control study
    • DOI 10.1111/j.1365-2133.2007.07986.x
    • Gisondi P., Tessari G., Conti A., Piaserico S., Schianchi S., Peserico A., Giannetti A., Girolomoni G., Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. The British Journal of Dermatology 2007 157 1 68 73 2-s2.0-34250674798 10.1111/j.1365-2133.2007.07986.x (Pubitemid 46934281)
    • (2007) British Journal of Dermatology , vol.157 , Issue.1 , pp. 68-73
    • Gisondi, P.1    Tessari, G.2    Conti, A.3    Piaserico, S.4    Schianchi, S.5    Peserico, A.6    Giannetti, A.7    Girolomoni, G.8
  • 9
    • 58049198305 scopus 로고    scopus 로고
    • Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome
    • 2-s2.0-58049198305 10.1001/archderm.144.12.1571
    • Chen Y.-J., Wu C.-Y., Shen J.-L., Chu S.-Y., Chen C.-K., Chang Y.-T., Chen C.-M., Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome. Archives of Dermatology 2008 144 12 1571 1575 2-s2.0-58049198305 10.1001/archderm.144.12.1571
    • (2008) Archives of Dermatology , vol.144 , Issue.12 , pp. 1571-1575
    • Chen, Y.-J.1    Wu, C.-Y.2    Shen, J.-L.3    Chu, S.-Y.4    Chen, C.-K.5    Chang, Y.-T.6    Chen, C.-M.7
  • 10
    • 33745861300 scopus 로고    scopus 로고
    • Inflammation and insulin resistance
    • 2-s2.0-33745861300 10.1172/JCI29069
    • Shoelson S. E., Lee J., Goldfine A. B., Inflammation and insulin resistance. Journal of Clinical Investigation 2006 116 7 1793 1801 2-s2.0-33745861300 10.1172/JCI29069
    • (2006) Journal of Clinical Investigation , vol.116 , Issue.7 , pp. 1793-1801
    • Shoelson, S.E.1    Lee, J.2    Goldfine, A.B.3
  • 11
    • 38949205723 scopus 로고    scopus 로고
    • Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: A 3-year weight loss study
    • DOI 10.1530/EJE-07-0721
    • Madsen E. L., Rissanen A., Bruun J. M., Skogstrand K., Tonstad S., Hougaard D. M., Richelsen B., Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. European Journal of Endocrinology 2008 158 2 179 187 2-s2.0-38949205723 10.1530/EJE-07-0721 (Pubitemid 351298534)
    • (2008) European Journal of Endocrinology , vol.158 , Issue.2 , pp. 179-187
    • Madsen, E.L.1    Rissanen, A.2    Bruun, J.M.3    Skogstrand, K.4    Tonstad, S.5    Hougaard, D.M.6    Richelsen, B.7
  • 12
    • 0018099294 scopus 로고
    • Severe psoriasis - oral therapy with a new retinoid
    • Fredriksson T., Pettersson U., Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978 157 4 238 244 2-s2.0-0018099294 (Pubitemid 8387357)
    • (1978) Dermatologica , vol.157 , Issue.4 , pp. 238-244
    • Fredriksson, T.1    Pettersson, U.2
  • 13
    • 4644309388 scopus 로고    scopus 로고
    • Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician's global assessment
    • DOI 10.1016/j.jaad.2004.04.012, PII S0190962204010886
    • Langley R. G., Ellis C. N., Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician's global assessment. Journal of the American Academy of Dermatology 2004 51 4 563 569 2-s2.0-4644309388 10.1016/j.jaad.2004.04.012 (Pubitemid 39278075)
    • (2004) Journal of the American Academy of Dermatology , vol.51 , Issue.4 , pp. 563-569
    • Langley, R.G.1    Ellis, C.N.2
  • 14
    • 27744503544 scopus 로고    scopus 로고
    • Translating the science of quality of life into practice: What do dermatology life quality index scores mean?
    • 2-s2.0-27744503544 10.1111/j.0022-202X.2005.23621.x
    • Hongbo Y., Thomas C. L., Harrison M. A., Salek M. S., Finlay A. Y., Translating the science of quality of life into practice: what do dermatology life quality index scores mean? Journal of Investigative Dermatology 2005 125 4 659 664 2-s2.0-27744503544 10.1111/j.0022-202X.2005.23621.x
    • (2005) Journal of Investigative Dermatology , vol.125 , Issue.4 , pp. 659-664
    • Hongbo, Y.1    Thomas, C.L.2    Harrison, M.A.3    Salek, M.S.4    Finlay, A.Y.5
  • 15
    • 14244250511 scopus 로고    scopus 로고
    • Psoriasis assessment tools in clinical trials
    • DOI 10.1136/ard.2004.031237
    • Feldman S. R., Krueger G. G., Psoriasis assessment tools in clinical trials. Annals of the Rheumatic Diseases 2005 64 supplement 2 ii65 ii68 2-s2.0-14244250511 10.1136/ard.2004.031237 (Pubitemid 40288526)
    • (2005) Annals of the Rheumatic Diseases , vol.64 , Issue.SUPPL. 2
    • Feldman, S.R.1    Krueger, G.G.2
  • 16
    • 1842567124 scopus 로고    scopus 로고
    • Validity and realiability of patient reported outcomes used in psoriasis: Results from two randomized clinical trials
    • DOI 10.1186/1477-7525-1-53
    • Shikiar R., Bresnahan B. W., Stone S. P., Thompson C., Koo J., Revicki D. A., Validity and realiability of patient reported outcomes used in psoriasis: results from two randomized clinical trials. Health and Quality of Life Outcomes 2003 1, article 53 2-s2.0-1842567124 10.1186/1477-7525-1-53 (Pubitemid 39111943)
    • (2003) Health and Quality of Life Outcomes , vol.1 , pp. 53
    • Shikiar, R.1    Bresnahan, B.W.2    Stone, S.P.3    Thompson, C.4    Koo, J.5    Revicki, D.A.6
  • 17
    • 4644312879 scopus 로고    scopus 로고
    • Psoriasis remission after laparoscopic Roux-en-Y gastric bypass for morbid obesity
    • DOI 10.1381/0960892041975569
    • Higa-Sansone G., Szomstein S., Soto F., Brasecsco O., Cohen C., Rosenthal R. J., Psoriasis remission after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obesity Surgery 2004 14 8 1132 1134 2-s2.0-4644312879 10.1381/0960892041975569 (Pubitemid 39299743)
    • (2004) Obesity Surgery , vol.14 , Issue.8 , pp. 1132-1134
    • Higa-Sansone, G.1    Szomstein, S.2    Soto, F.3    Brasecsco, O.4    Cohen, C.5    Rosenthal, R.J.6
  • 19
    • 55849143623 scopus 로고    scopus 로고
    • Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: A randomized, controlled, investigator-blinded clinical trial
    • 2-s2.0-55849143623 10.3945/ajcn.2008.26427
    • Gisondi P., del Giglio M., Di Francesco V., Zamboni M., Girolomoni G., Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. American Journal of Clinical Nutrition 2008 88 5 1242 1247 2-s2.0-55849143623 10.3945/ajcn.2008.26427
    • (2008) American Journal of Clinical Nutrition , vol.88 , Issue.5 , pp. 1242-1247
    • Gisondi, P.1    Del Giglio, M.2    Di Francesco, V.3    Zamboni, M.4    Girolomoni, G.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.